R&D OPERATIONS

OverviewPersonnel CostsEntity & JurisdictionProject EvidenceActivity EvidenceR&D Hours

BY ROLE

CTOCFOHead of TaxHead of R&DFinance / ControllingFounder / CEO

BY OUTCOME

Continuous DocumentationAudit DefenseMaximize the ClaimMulti-jurisdiction

BY COMPANY STAGE

StartupsGrowing CompaniesEnterprise & Groups

R&D Funding Estimator

Investment Case

OverviewEquity Story

Share & Analysts

ShareAnalystsShareholder StructureBasic Information

Investor News

Corporate NewsAd-Hoc AnnouncementsDirectors' Dealings

Corporate Governance

Executive BoardSupervisory BoardArticles of Association

Events & Publications

Financial CalendarFinancial PublicationsAnnual General Meeting

Max Hunger

Max HungerHead of Investor Relations

ir@innoscripta.com

+49 (0)89 255 553 509

CompanyPublic BenefitCareersBlog & MediaCustomer StoriesSocial ImpactPartnersTrust CenterContact Us

How Kämper Drahtumformtechnik accelerated automation and boosted efficiency with innoscriptaRead the story

Overview Personnel Costs Entity & Jurisdiction Project Evidence Activity Evidence R&D Hours

BY ROLECTO CFO Head of Tax Head of R&D Finance / Controlling Founder / CEOBY OUTCOMEContinuous Documentation Audit Defense Maximize the Claim Multi-jurisdictionBY COMPANY STAGEStartups Growing Companies Enterprise & Groups R&D Funding Estimator

Investment CaseOverview Equity StoryShare & AnalystsShare Analysts Shareholder Structure Basic InformationInvestor NewsCorporate News Ad-Hoc Announcements Directors' DealingsCorporate GovernanceExecutive Board Supervisory Board Articles of AssociationEvents & PublicationsFinancial Calendar Financial Publications Annual General Meeting

Company Public Benefit Careers Blog & Media Customer Stories Social Impact Partners Trust Center Contact Us

Blog & Media

Ideas & Updates from innoscripta

Explore stories, insights, and innovations from the people building the future of R&D and digital tax technology.

Sep 14, 2026

German Research Allowance: Key trends, sector insights, and how to claim

Sep 10, 2026

Sustainable R&D: Leveraging the Forschungszulage for high-impact GreenTech

Sep 07, 2026

Forschungszulage for Germany's automotive industry

Sep 03, 2026

How international R&D incentives impact financial statements: A guide for CFOs

Aug 31, 2026

Research Allowance for health and pharmaceutical research in Germany

Aug 27, 2026

SMEs in Germany – Criteria, funding opportunities and benefits of the R&D tax incentive

Aug 24, 2026

How can project documentation software deliver the greatest advantage?

Aug 21, 2026

IT BOLTWISE highlights the Forschungszulage as a strategic factor for innovation in the IT industry

Aug 20, 2026

Personnel cost documentation for Forschungszulage 2026

Ready to Take the Next Step?

Our experts can help you assess your eligibility, structure your R&D documentation, and maximize the benefits of the Research Allowance.

The data layer for R&D, a continuous, verifiable record of the work your teams actually do, captured at source. Publicly listed, ISO 27001-certified, in 20+ countries.

innoscripta provides software solutions, documentation support, and general information on R&D funding. Our services do not include individual tax, legal, or financial advice.

Eligibility, funding rates, and potential outcomes depend on the applicable laws and regulations as well as the specific circumstances of the company and the respective project. Before submitting an application, we therefore recommend seeking qualified tax, legal, or financial advice where appropriate.

For further information, please refer to our information notice.

Platform

Overview Personnel Costs Entity & Jurisdiction Project Evidence Activity Evidence R&D Hours

Solutions

CTO CFO Head of Tax Head of R&D Finance / Controlling Founder / CEO

Continuous Documentation Audit Defense Maximize the Claim Multi-jurisdiction

Startups Growing Companies Enterprise & Groups

TOOLS

R&D Funding Map R&D Funding Estimator

Investors

Investment Case Share & Analysts Investor News Corporate Governance Events & Publications

About us

Company Public Benefit Careers Blog & Media Customer Stories Social Impact Partners Trust Center Contact Us

Imprint Disclaimer & Privacy policy

Copyright © 2026 - innoscripta SE

120 Wall Street, Fl 20, New York, USA

+1 315 758 3827

info@innoscripta.com